There are 805 resources available
14P - Enhancing quality of life and reducing inflammation in postmenopausal breast cancer survivors receiving aromatase inhibitors through supplementation with fish oil and evening primrose oil: A pilot randomized placebo-controlled trial
Presenter: Vesna Vucic
Session: Poster Display session
Resources:
Abstract
15P - HER2-positive breast cancer in a low-middle income country (LMIC): Lack of pathology capability and the urgent need for targeted treatment
Presenter: Thi Hoai Hoang
Session: Poster Display session
Resources:
Abstract
16P - Prognostic significance of HER2-Low early-stage breast cancer at King Chulalongkorn Memorial Hospital: A single center, retrospective study
Presenter: polawat angsulajit
Session: Poster Display session
Resources:
Abstract
17P - To use or not to use adjuvant trastuzumab emtansine in early breast cancer in resource constrained settings: Can residual cancer burden (RCB) help us to stratify risk of residual disease?
Presenter: Vijai Simha
Session: Poster Display session
Resources:
Abstract
18P - A comparative real-world non inferiority study on radiation-induced acute esophagitis in the era of hypofractionated radiotherapy for Ca breast
Presenter: Sai Sunayana Gopireddy
Session: Poster Display session
Resources:
Abstract
19P - Molecular subtyping and prediction of risk of recurrence for early stage receptor positive breast cancer for using Nanostring nCounter: First study from India
Presenter: Vijayalakshmi Ramshankar
Session: Poster Display session
Resources:
Abstract
20P - Exploring the impact of neoadjuvant therapy on suicide risk among breast cancer patients: A comprehensive retrospective study and mendelian randomization analysis
Presenter: Yushuai Yu
Session: Poster Display session
Resources:
Abstract
22P - Usefulness of neutrophil-to-lymphocyte ratios to predict pathologic response and prognosis in patients with operable breast cancer receiving neoadjuvant chemotherapy with nab-paclitaxel
Presenter: Nakamura Yugo
Session: Poster Display session
Resources:
Abstract
23P - Clinicopathological features of HR+/HER2 low breast cancer in a real-world setting in China
Presenter: Zhang Min
Session: Poster Display session
Resources:
Abstract
24TiP - A phase III, randomized study of adjuvant sacituzumab tirumotecan (sac-TMT) plus pembrolizumab vs treatment of physician’s choice (TPC) in patients with TNBC who received neoadjuvant therapy and did not achieve a pathological complete response (pCR) at surgery
Presenter: Rebecca Dent
Session: Poster Display session
Resources:
Abstract